VITE SAUD : Call Notice Of Extraordinary Shareholders ‘Meeting

ADVANCED DIGITAL HEALTH MEDICINA PREVENTIVA S.A. ('Company') shareholders are invited to attend, at a first call, the Extraordinary Shareholders' Meeting to be held on January 20, 2017, at 3:00 pm, at the Company's headquarters, located in the City of Barueri, State of São Paulo, at Al. Tocantins, 125, CEP 06455-931, with the following agenda: (i) a reverse stock split of the 30,250,395 (thirty million, two hundred and fifty thousand, three hundred and ninety-five) registered common shares with no par value of the Company, in the proportion of 4 (four) shares to form 1 (one) share, without modification of the capital stock, resulting in 7,562,598 (seven million, five hundred and sixty-two thousand, five hundred and ninety-eight) registered common shares, with no par value, issued by the Company, pursuant to the proposal of the Board of Directors; (ii) amendment of Clause 3.1 of the Company's bylaws to contemplate the new number of shares into which the capital stock is divided after the reverse split; (iii) empowerment of the Company's Officers to take all necessary measures to operationalize and effect the reverse stock split.

General Information: Pursuant to the provisions of Law 6,404/76 and CVM Instruction 481/09, all documents and information necessary for the deliberation of the matters included in the agenda are available to shareholders at the Company's headquarters and (a) at the Company's web page (www.vitalyzeme.com.br); (b) at the Brazilian Securities and Exchange Commission website (www.cvm.gov.br); and (c) at BM&FBOVESPA S.A. - Securities, Commodities and Futures Exchange (www.bmfbovespa.com.br), through the IPE system,.

Proof of the Quality of Shareholder or Representative: Shareholders must attend the Extraordinary General Meeting with an identity document with photo and proof of ownership of shares issued by the Company, issued by the depositary financial institution. In the event of representation, in addition to compliance with article 126 of Law 6404/76: (i) the instruments of mandate must have the signature of the grantor recognized; (ii) in the case of legal entities or investment funds, certified copies of the corporate acts evidencing legal representation must be submitted; And (iii) in the case of documents in a foreign language, these must be notarized, consularized, or apostilled, translated into Portuguese by sworn translation and registered in a Registry of Deeds and Documents. Shareholders who are represented by a proxy may send the representation documents in advance to the Extraordinary Shareholders' Meeting for the Company.

To access the document, click here.

Barueri, January 2, 2017.